Exploiting the T790M Mutation: Sulfur-Anchoring as a New Paradigm for Non-Covalent EGFR Inhibition
Authors:
- Shrikant S. NilewarSNShrikant S. Nilewar
- Shuvadip KhanraShuvadip Khanra
- Manav PandyaMPManav Pandya
- Sandesh LodhaSLSandesh Lodha
- Perli Kranti KumarPerli Kranti Kumar
- Nagaraju BandaruNBNagaraju Bandaru
- Antonio Jose Naranjo-RedondoANAntonio Jose Naranjo-Redondo
- Ricardo Pérez-Pastén-BorjaRicardo Pérez-Pastén-Borja
- Tushar Janardan PawarTushar Janardan Pawar
Preprint
- 29 April 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: The EGFR T790M gatekeeper mutation drives resistance in non-small cell lung cancer by sterically hindering inhibitors and restoring ATP affinity. As emerging C797S mutations render covalent inhibitors obsolete, novel non-covalent strategies are critical. This study identifies inhibitors that redefine the mutant methionine sulfur atom as a primary stabilizing anchor rather than a liability. Methods: A reinforcement learning-based generative AI framework (DrugEx) sampled 100,000 molecules, prioritized through QSAR-based classification (mean ROC-AUC: 0.91 ± 0.01) and physicochemical filtering. Four lead candidates underwent 200 ns all-atom molecular dynamics (MD) simulations. Mechanistic stability and energetic convergence were quantified via Free Energy Landscape (FEL) analysis, post-simulation Ramachandran validation, and ensemble-averaged Molecular Mechanics Generalized Born Surface Area (MM-GBSA) binding free energy calculations. Results: Candidate 106 demonstrated high mutation tolerance by redistributing interactions toward the Met790 sulfur atom, contrasting with reference scaffolds 14 and 88 which suffered significant affinity loss. MD analysis revealed that potency is fundamentally dictated by successful recruitment of the thioether environment, locking the complex within a narrow, well-defined thermodynamic basin. Candidate 106 maintained stable binding (−11.0 kcal/mol by docking) corroborated by a robust MM-GBSA ΔGbind of −50.51 kcal/mol, primarily driven by persistent π-sulfur contacts (85% occupancy). Ramachandran analysis confirmed over 90% favored region occupancy, ensuring interactions occur without non-physical protein strain. Conclusions: Successful T790M/C797S resistance bypass is achievable by exploiting the gatekeeper methionine’s electronic environment. This mutation-aware blueprint provides a non-covalent strategy that avoids the metabolic and resistance-prone liabilities of covalent warheads.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Generative Deep Learning for de Novo Drug Design─A Chemical Space OdysseyJournal of Chemical Information and Modeling, 2025
- DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical SpaceJournal of Chemical Information and Modeling, 2023
- Beyond Osimertinib: The Development of Third-Generation EGFR Tyrosine Kinase Inhibitors For Advanced EGFR+ NSCLCJournal of Thoracic Oncology, 2021
- Generative chemistry: drug discovery with deep learning generative modelsJournal of Molecular Modeling, 2021
- Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitorsBioorganic & Medicinal Chemistry, 2013
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialThe Lancet Oncology, 2012
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor SensitivityCancer Cell, 2007
- Sulfur–Aromatic Interactions: A Computational Study of the Dimethyl Sulfide–Benzene ComplexBioorganic Chemistry, 1997
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997